Dr. Martens Plc () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Negative results for the last 4 consecutive quarters

ROCE(HY) Lowest at 1.23%
NET PROFIT(Q) At GBP 32.11 MM has Fallen at -36.03%
PRE-TAX PROFIT(Q) Fallen at -29.17%

With ROE of 7.52%, it has a expensive valuation with a 2.57 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Footwear

Market cap

GBP 742 Million (Small Cap)

P/E

34.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.60

Return on Equity

-999,999.00%

Price to Book

2.26

Revenue and Profits:

Net Sales:

34 Million

(Quarterly Results - Sep 2010)

Net Profit:

7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.52%

6 Months

32.16%

1 Year

14.89%

2 Years

-17.59%

3 Years

-62.24%

4 Years

-80.3%

5 Years

0.0%

Dr. Martens Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

19.84%

EBIT Growth (5y)

147.01%

EBIT to Interest (avg)

7.92

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.37

Sales to Capital Employed (avg)

0.21

Tax Ratio

10.79%

Dividend Payout Ratio

542.55%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.57

EV to EBIT

29.77

EV to EBITDA

25.45

EV to Capital Employed

2.15

EV to Sales

8.43

PEG Ratio

Dividend Yield

ROCE (Latest)

7.21%

ROE (Latest)

7.52%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'10 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2010 is 35.43% vs -48.48% in Sep 2009",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2010 is 52.17% vs -53.54% in Sep 2009",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'10",
        "Sep'09",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.40",
          "val2": "25.40",
          "chgp": "35.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.50",
          "val2": "9.40",
          "chgp": "22.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "1.70",
          "chgp": "105.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.00",
          "val2": "4.60",
          "chgp": "52.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 10.13% vs 17.50% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is -28.86% vs 422.19% in Mar 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,000.30",
          "val2": "908.30",
          "chgp": "10.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "245.00",
          "val2": "269.40",
          "chgp": "-9.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.70",
          "val2": "15.00",
          "chgp": "24.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.90",
          "val2": "-0.20",
          "chgp": "-1,850.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "128.90",
          "val2": "181.20",
          "chgp": "-28.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "190.70%",
          "val2": "256.20%",
          "chgp": "-6.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'10 - YoY

Sep'10

Sep'09

Change(%)

Net Sales

34.40

25.40

35.43%

Operating Profit (PBDIT) excl Other Income

11.50

9.40

22.34%

Interest

3.50

1.70

105.88%

Exceptional Items

0.00

Consolidate Net Profit

7.00

4.60

52.17%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2010 is 35.43% vs -48.48% in Sep 2009

Consolidated Net Profit

YoY Growth in quarter ended Sep 2010 is 52.17% vs -53.54% in Sep 2009

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'23

Mar'23

Mar'22

Change(%)

Net Sales

1,000.30

908.30

10.13%

Operating Profit (PBDIT) excl Other Income

245.00

269.40

-9.06%

Interest

18.70

15.00

24.67%

Exceptional Items

-3.90

-0.20

-1,850.00%

Consolidate Net Profit

128.90

181.20

-28.86%

Operating Profit Margin (Excl OI)

190.70%

256.20%

-6.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2023 is 10.13% vs 17.50% in Mar 2022

Consolidated Net Profit

YoY Growth in year ended Mar 2023 is -28.86% vs 422.19% in Mar 2022

All Annual Results

Company CV

About Dr. Martens Plc

Dr. Martens Plc

Footwear

No Details Available.

Company Coordinates

No Company Details Available